Table 3 Time period of clinically useful contrast enhancement after CA injection
From: Endocardial border delineation capability of a novel multimodal polymer-shelled contrast agent
CA (injected dose) | Clinically useful time period |
|---|---|
SonoVue (1.5 ml) | 20–40 s |
Polymer-shelled CA (1.5 ml) | 0–20 s |
Polymer-shelled CA (3 ml) | 0–20 s |
Polymer-shelled CA (5 ml) | 20–40 s |